Download video

From Insulin Resistant to Insulin Sensitive in 10 Weeks - Exercise Plan

1.5K views

Dr. Becky Gillaspy

Streamed 2 hours ago

From Insulin Resistant to Insulin Sensitive in 10 Weeks - Exercise Plan

From Insulin Resistant to Insulin Sensitive in 10 Weeks - Exercise Plan

If COVID Came from a Lab… Why Are We Acting Like It’s Gone?
14:35
If COVID Came from a Lab… Why Are We Acting Like It’s Gone?
by Vejon Health
202510141508
3:21
202510141508
by Informatics
What’s New in 22q ? Podcast Episode 11 - Oxytocin Seals Brain Barriers in 22q11.2DS Mice
13:07
What’s New in 22q ? Podcast Episode 11 - Oxytocin Seals Brain Barriers in 22q11.2DS Mice
by 22q11 Europe
Venous Insufficiency — Part 2: Diagnosis and Treatment
7:57
Venous Insufficiency — Part 2: Diagnosis and Treatment
by The Learning Stethoscope
Phase 2b shows sonlicromanol's disease-modifying potential in mitochondrial disease.
4:32
Phase 2b shows sonlicromanol's disease-modifying potential in mitochondrial disease.
by Khondrion
New Drug Approvals Inluriyo (imlunestrant), Palsonify (paltusotine), and Rhapsido (remibrutinib)
18:30
New Drug Approvals Inluriyo (imlunestrant), Palsonify (paltusotine), and Rhapsido (remibrutinib)
by Medication Academy
What are Iatrogens ?
0:41
What are Iatrogens ?
by Sciwords
Potency and efficacy of PIP4K2 inhibitors in ALL: looking forward to first-in-human trials
0:52
Potency and efficacy of PIP4K2 inhibitors in ALL: looking forward to first-in-human trials
by VJHemOnc – Video Journal of Hematology \& HemOnc
pseudoscientific practices
3:52
pseudoscientific practices
by 2Visions
GMT20220316 225207 Recording 1920x1080
51:32
GMT20220316 225207 Recording 1920x1080
by Fuse Medical
Microsoft EXTENDS Defender Protection on Windows 10 Until 2028!
3:00
Microsoft EXTENDS Defender Protection on Windows 10 Until 2028!
by BrenTech
Robust and Durable Immune Response: Virus-Like Particle Vaccines
1:38
Robust and Durable Immune Response: Virus-Like Particle Vaccines
by astrazeneca
Vascular Malformations
4:14
Vascular Malformations
by Neuro-Ophthalmology with Dr. Andrew G. Lee
Long-term follow-up of a Phase II study combining azacitidine with CHOP in previously untreated PTCL
3:48
Long-term follow-up of a Phase II study combining azacitidine with CHOP in previously untreated PTCL
by VJHemOnc – Video Journal of Hematology \& HemOnc
TU2218, a TGFβ-RI and VEGFR2 dual inhibitor, with pembrolizumab in solid tumors
1:10
TU2218, a TGFβ-RI and VEGFR2 dual inhibitor, with pembrolizumab in solid tumors
by VJOncology
Expansion of phenotypically modified type 2 memory B cells after allergen immunotherapy
6:13
Expansion of phenotypically modified type 2 memory B cells after allergen immunotherapy
by Allergy
Disease Clusters \& Their Cause PART 2: Why Some Neighborhoods Have High Disease Rates!
15:13
Disease Clusters \& Their Cause PART 2: Why Some Neighborhoods Have High Disease Rates!
by aquifersandhealth
Phase 2 NOBLE Study
3:27
Phase 2 NOBLE Study
by CheckRare
IndEx-2: Assessing the impact of antigen density on the efficacy \& safety of immunotherapies
29:00
IndEx-2: Assessing the impact of antigen density on the efficacy \& safety of immunotherapies
by RoukenBio
One of these is not like the others: A descriptive study of the attenuated phenotype of PMS2
1:38
One of these is not like the others: A descriptive study of the attenuated phenotype of PMS2
by VJOncology
New molecular target for disrupting development of venous malformations
1:48
New molecular target for disrupting development of venous malformations
by AJE Video Bytes
A new signaling pathway links pyroptosis and acute kidney injury after renal I\/R
1:33
A new signaling pathway links pyroptosis and acute kidney injury after renal I\/R
by AJE Video Bytes